Hjem › Aterosklerose › Mississippi
Aterosklerose kliniske forsøg i Mississippi
4 studier for Aterosklerose søger deltagere på steder i Mississippi.
Officiel studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Olive Branch Family Medical Center, Olive Branch
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Jackson Heart Clinic, Jackson
- Cardiology Associates of North Mississippi, Tupelo
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology Associates, PC, Columbus
- - Nephrology and Hypertension Associates Ltd, Tupelo
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961Pelacarsen Roll-over Extension Program
- Elite Clinical Research, Jackson
- Stern Cardiovascular Foundation Inc, Southaven
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 29. jul. 2026 · NCT06875973Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.